Tor Peters
CEO since 2024 and member of the board since 2009.
Education: Bachelor of Science, University of Lund, Sweden and an MBA from IMD in Switzerland.
Background: A Swedish national with over 30 years of experience in senior positions at various Medtech companies, including BOC Ohmeda, Novo Nordisk, Scimed and Boston Scientific. Founder of several Medtech ventures and in 1996 co-founded JOMED, an innovative European interventional cardiology company, achieving the largest global Medtech IPO in 2000. Joined Occlutech in 2005 and held the position as President & CEO from 2009 to 2017 and Co-CEO from 2018 to 2020.
Other current positions: Board member of SIC Invent Switzerland and CSW Therapeutics AB.
Pascale Brasseur
Executive VP of Clinical Operations since 2023.
Education: Master of Science in Health Economics from Université Claude Bernard in Lyon, France. Executive education (Advanced Strategy and Leadership Program), Wharton School of the University of Pennsylvania, USA.
Background: 25 years of experience in health economics, outcomes research and reimbursement policy within the healthcare industry, with a unique perspective gained from working in both the medical device and pharmaceutical sectors. Among other experiences, a 15-year tenure at Medtronic leading market access activities for Cardiovascular in the EMEA Region and for Spine at a global level.
Johan Sundell
CFO since 2023 and CFO and Deputy CEO since 2025.
Education: Master of Science BA, Business Management from Lund University in Lund, Sweden.
Background: 25 years of experience in leading roles in finance with companies like BE Group Sverige and Brio AB. Most recently, Johan held the role as CFO of Caldic Nordics, a global solutions provider for innovative and sustainable solutions in life science and specialty chemicals.
Frank Dallmann
Executive VP Operations since 2023.
Education: Degree in Mechanical Engineering, Design and Product development from the Technical University in Dresden, Germany.
Background: 24 years of international experience in Operations and Research & Development of medical devices. Among other experiences as Head of Shoulder Development at Mathys Ltd. Bettlach in Germany and Switzerland.
Nils Kästner
VP Regulatory Affairs & Quality since 2025.
Education: Science Degree in Physics from Friedrich Schiller University, Jena, Germany.
Background: Over 10 years of experience in the medical device industry, with a strong focus on Quality Management and Regulatory Affairs. Previously led the development and restructuring of quality management systems and high-risk product design, including implantable devices. Held roles in regulatory compliance across international markets. Known for building strong teams, streamlining processes, and driving regulatory excellence.
Floriano Scienza
VP Marketing & Business Development since 2025.
Education: Science Degree in Biomedical Engineering from Politecnico di Milano, Italy, and Master in Business Administration from ISTUD, Italy.
Background: 21 years of experience in Cardiovascular MedTech space, holding Sales and Marketing positions at Medtronic, Abbott and AtriCure.
Cansel Isikli
VP R&D since 2025.
Education: PhD candidate in Neuroscience from Koç University, Turkey and MSc. Biomedical Engineering from Middle East Technical University, Turkey.
Background: Over 15 years of experience in the medical device industry, specializing in R&D, regulatory affairs, and quality assurance for cardiovascular, biodegradable, and orthopedic implants. Led the development and registration of Class III medical devices and supported companies in MDR transition, CE mark renewals, and regulatory compliance. Founder of Prem R&D Consulting and CERES Healthcare Technologies, with a strong focus on healthcare innovation.
